Baxter International Inc. (NYSE:BAX) said that it plans to spin off its kidney care units into an independent, publicly traded company in the next 12-18 months. Baxter is also exploring alternatives for its BioPharma Solutions business, including a potential sale or other separation options, the company said.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
34.64 USD | +1.99% |
|
+1.53% | -10.68% |
12:17pm | North American Morning Briefing : Retail Sales, -2- | DJ |
Jul. 15 | Medical Technology Companies Poised for Another 'Solid' Quarter, Morgan Stanley Says | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.68% | 17.31B | |
-6.45% | 179B | |
-6.05% | 98.84B | |
-6.56% | 65.34B | |
+15.46% | 45.41B | |
-7.29% | 44.94B | |
+9.68% | 43.76B | |
+13.10% | 29.01B | |
+19.39% | 25.65B | |
-6.90% | 23.32B |
- Stock Market
- Equities
- BAX Stock
- News Baxter International Inc.
- Baxter International Plans to Spin Off Kidney Care Units